Molina Healthcare Inc (MOH) Upgraded to “Buy” by ValuEngine

ValuEngine upgraded shares of Molina Healthcare Inc (NYSE:MOH) from a hold rating to a buy rating in a research note released on Thursday.

Other analysts have also issued reports about the company. BidaskClub lowered Molina Healthcare from a strong-buy rating to a buy rating in a research note on Friday, July 28th. TheStreet lowered Molina Healthcare from a b rating to a c rating in a research note on Monday, August 7th. Jefferies Group LLC boosted their target price on Molina Healthcare from $60.00 to $64.00 and gave the company a hold rating in a research note on Friday, October 13th. Deutsche Bank AG restated a hold rating and issued a $72.00 target price on shares of Molina Healthcare in a research note on Wednesday, August 9th. Finally, Zacks Investment Research upgraded Molina Healthcare from a sell rating to a hold rating in a research report on Monday, November 6th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the company. Molina Healthcare presently has a consensus rating of Hold and a consensus price target of $64.30.

Shares of Molina Healthcare (NYSE MOH) traded up $0.30 during trading on Thursday, reaching $76.90. The company had a trading volume of 1,006,000 shares, compared to its average volume of 1,274,616. The company has a market capitalization of $4,450.00, a price-to-earnings ratio of 23.88 and a beta of 0.91. Molina Healthcare has a 1-year low of $42.56 and a 1-year high of $80.65. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The business’s revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.85 earnings per share. research analysts anticipate that Molina Healthcare will post -3.88 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Molina Healthcare Inc (MOH) Upgraded to “Buy” by ValuEngine” was posted by Markets Daily and is the property of of Markets Daily. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.themarketsdaily.com/2017/11/13/molina-healthcare-inc-moh-upgraded-to-buy-by-valuengine.html.

In related news, Director Daniel Cooperman sold 4,500 shares of the business’s stock in a transaction dated Tuesday, November 7th. The stock was sold at an average price of $78.79, for a total transaction of $354,555.00. Following the completion of the transaction, the director now directly owns 9,087 shares in the company, valued at $715,964.73. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John C. Molina sold 25,295 shares of the business’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $59.33, for a total value of $1,500,752.35. Following the transaction, the director now owns 585,859 shares of the company’s stock, valued at $34,759,014.47. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 368,458 shares of company stock valued at $24,010,639. 6.20% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in Molina Healthcare by 1.9% during the second quarter. Vanguard Group Inc. now owns 3,619,435 shares of the company’s stock worth $250,392,000 after purchasing an additional 66,206 shares during the last quarter. Tiedemann Wealth Management LLC lifted its stake in Molina Healthcare by 7.8% during the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after purchasing an additional 103,775 shares during the last quarter. Northern Trust Corp lifted its stake in Molina Healthcare by 14.5% during the second quarter. Northern Trust Corp now owns 900,946 shares of the company’s stock worth $62,328,000 after purchasing an additional 113,808 shares during the last quarter. Rothschild Asset Management Inc. lifted its stake in Molina Healthcare by 6.1% during the third quarter. Rothschild Asset Management Inc. now owns 706,683 shares of the company’s stock worth $48,592,000 after purchasing an additional 40,737 shares during the last quarter. Finally, Scout Investments Inc. lifted its stake in Molina Healthcare by 36.6% during the second quarter. Scout Investments Inc. now owns 614,535 shares of the company’s stock worth $42,514,000 after purchasing an additional 164,677 shares during the last quarter. 95.04% of the stock is owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply